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Photorhabdus luminescens TTO1 and Xenorhabdus nematophila HGB081 are insect
pathogenic bacteria and producers of various structurally diverse bioactive natural
products. In these entomopathogenic bacteria we investigated the role of the global
regulators Lrp, LeuO, and HexA in the production of natural products. Lrp is a general
activator of natural product biosynthesis in X. nematophila and for most compounds in
TTO1. Microarray analysis confirmed these results in X. nematophila and enabled the
identification of additional biosynthesis gene clusters (BGC) regulated by Lrp. Moreover,
when promoters of two X. nematophila BGC were analyzed, transcriptional activation
by Lrp was observed. In contrast, LeuO in X. nematophila and P. luminescens has
both repressing and activating features, depending on the natural product examined.
Furthermore, heterologous overexpression of leuO from X. nematophila in the closely
related Xenorhabdus szentirmaii resulted in overproduction of several natural products
including novel compounds. The presented findings could be of importance for
establishing a tool for overproduction of secondary metabolites and subsequent
identification of novel compounds.
Keywords: transcription factors, Photorhabdus, Xenorhabdus, natural product, regulation of natural products
INTRODUCTION
Bacterial natural products are of great importance for our current health system and the
development of new therapeutic agents or plant protectants (Zhou et al., 2008; Newman and
Cragg, 2012). The entomopathogenic bacterial genera Photorhabdus and Xenorhabdus are potent
producers of structurally diverse compounds (Figure 1) that are important during their mutualistic
lifestyle in symbiosis with nematodes, the infection of insect larvae and protection of the host
cadaver against competitors (Thomas and Poinar, 1979). Within the last few years, advances
in understanding regulation in entomopathogenic bacteria have been made, but a general view
regarding natural product biosynthesis and function is missing.
Lrp (leucine responsive protein) and LeuO have both been described as global regulators of
transcription in Escherichia coli (Tani et al., 2002; Shimada et al., 2009) and Salmonella enterica
(Baek et al., 2009; Dillon et al., 2012). Lrp type regulators are widespread in the bacterial world
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FIGURE 1 | Examples of natural products from P. luminescens TTO1, X. nematophila HGB081, and X. szentirmaii.
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(Brinkman et al., 2003) and are sensors of several amino
acids and thus generally associated with response to nutrient
availability (Brinkman et al., 2003; Hart and Blumenthal,
2011). Lrp in S. enterica reduces virulence by repressing
genes in the Salmonella pathogenicity island 1 (SPI-1) and
2 (SPI-2) (Baek et al., 2009) whereas in Vibrio, it has been
shown to be important for virulence (Lin et al., 2007). In
Xenorhabdus nematophila Lrp is also a global regulator and
affects mutualism with nematodes as well as pathogenicity in
insects (Cowles et al., 2007; Hussa et al., 2015). Regarding
secondary metabolite production, a lrp deletion mutant shows
no antibiotic activity toward Micrococcus luteus or Bacillus
subtilis while the wild type has antibiotic activity (Cowles
et al., 2007). In Photorhabdus an lrp mutant has reduced levels
of isopropylstilbene (IPS) and its precursor, cinnamic acid.
Additionally, Lrp activates PstlA, the promoter of the gene
responsible for cinnamic acid biosynthesis (Lango-Scholey et al.,
2013).
LeuO belongs to the largest family of transcriptional regulators
in prokaryotes, the LysR type transcriptional regulators (Pareja
et al., 2006; Hernández-Lucas and Calva, 2012). In S. enterica,
where it was first described (Hertzberg et al., 1980; Henikoff
et al., 1988) it indirectly acts as a repressor for SPI-1
(Espinosa and Casadesús, 2014) and is often described as an
antagonist of heat-stable nucleoid-structuring protein (H-NS)
(Chen and Wu, 2005). In Vibrio cholerae, however, LeuO
is part of the ToxR regulon and down-regulates important
virulence factors. The expression of leuO in V. cholerae is
activated by the natural product cyclo(Phe-Pro) (Bina et al.,
2013). In Vibrio parahaemolyticus a LeuO homolog is positively
controlled by ToxRS and negatively regulates transcription of
a type III secretion system (Whitaker et al., 2012). As the
production of secondary metabolites in X. nematophila and
Photorhabdus luminescens is important for virulence and LeuO
is described as a regulator for virulence factors in other bacterial
species, we investigated whether LeuO also plays a role in
the regulation of natural products in these entomopathogenic
bacteria.
HexA is a transcriptional repressor of the LysR type
family. In Photorhabdus temperata it has an important role
in the interaction with the nematode by repressing antibiotic
production within the host (Joyce and Clarke, 2003). Kontnik
et al. (2010) showed that 1hexA mutants of P. temperata and
P. luminescens produce significantly more IPS and derivatives
thereof compared to the wild type while anthraquinone
production is upregulated in the P. temperata mutant but
downregulated in P. luminescens 1hexA. Recently it was
observed that hexA is part of a regulatory cascade in which
it is controlled by Hfq. Deletion of hexA restores secondary
metabolite production in a 1hfq mutant which otherwise shows
very little production (Tobias et al., 2016).
In this study, the influence of the three global regulators
LeuO, Lrp, and HexA with the focus on secondary metabolite
production is described in P. luminescens and X. nematophila.
Furthermore, we examine the potential for heterologous




The strains used in this work are E. coli S17-1 λpir (Tpr Smr
recA thi hsdR RP4-2-Tc::MuKm::Tn7, λpir phage lysogen), E. coli
DH10B (Life Technologies), P. luminescens TTO1 (rifampicin
resistant strain) (Duchaud et al., 2003), X. nematophila ATCC
19061 (HGB800), X. nematophila AN6/1 (HGB081, rifampicin
resistant strain, isolated by S. Forst), X. nematophila lrp-2::Km
(HGB1059) (Cowles et al., 2007), and X. szentirmaii DSM 16338
(Lengyel et al., 2005).
Cultivation of Bacteria
Cells were generally grown in lysogeny broth (LB) with 0.5%
(w/v) NaCl or in SF-900 broth (GibcoTM) at 30◦C or 37◦C
(for E. coli), 200 rpm in Erlenmeyer flasks for liquid cultures.
LB plates contained 1.5% agar. Cultures for extraction were
inoculated from overnight pre-cultures with a starting OD600
of 0.1. For induction of PBAD, cultures were supplemented
with 0.2% (w/v) L-arabinose. Concentrations for antibiotics,
added when necessary, were kanamycin (50 µg/mL), rifampicin
(50 µg/mL), and chloramphenicol (20 µg/mL). PCR and Sanger
DNA sequencing were used to verify mutants.
Construction of Plasmids
Phusion polymerase (Finnzymes/Thermo Scientific) was used for
amplification of PCR products and plasmids were extracted using
a Miniprep Kit (Thermo Scientific). Plasmids and purified PCR-
products were digested with the described restriction enzymes
(Fermentas/Thermo Scientific), purified by gel electrophoresis,
extracted with GeneJETTM kit (Fermentas/Thermo Scientific),
ligated and transformed into E. coli via electroporation.
The pBAD30 plasmid (Guzman et al., 1995) was
amplified without bla via PCR (oligonucleotides: forward,
5′-CCATGGCATA TATACTTTAG ATTGATTTACG-3′;
reverse, 5′-CTCGAGTTCT GCTTAATTTG ATGC-3′) and
blunt-end ligated with Pamp-kanR (oligonucleotides: forward,
5′-CTCGAGGATA ATAATGGTTT CTTAGACG-3′; reverse,
5′-CCATGGAACT TGGTCTGACA GTTACC-3′) resulting in
pBAD30_kanR (p15A, araC, ara02, and ara01 sites, PBAD, kanR;
details and DNA sequence are depicted in the Supplementary
Table S1). Regulator genes leuO (TTO1: plu3672, 945 bp;
HGB081: XNC1_1043, 948 bp) and lrp (TTO1: plu1600, 495 bp;
HGB081: XNC1_1548, 495 bp) were amplified with overhangs
for restriction enzyme sites KpnI and PaeI from genomic DNA
(extracted with Qiagen Puregene Yeast/Bact. Kit) and subcloned
in pJET1.2 (Life Technologies). These restriction enzyme sites
were used for ligating the fragments into the corresponding
sites of pBAD30_kanR. E. coli DH10B was transformed with
this plasmid and LB kanamycin plates were used to screen for
positive clones.
For the construction of cluster expression plasmid (pCEP)
plasmids, the start of the genes leuO, lrp, and hexA from
P. luminescens TTO1 (oligonucleotides for leuO: forward, 5′-CAT
ATGGCTG AATACACCTC AGTAACTGC-3′; reverse, 5′-CTC
GAGGGTA ATGATGAAAAT CCATACG-3′, 547 bp;
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oligonucleotides for lrp: forward, 5′-CATATGATAG ATAATAA
AAA ACGTCCGGGA AAAGATC-3′; reverse, 5′-CTCGAGCT
GG CAAACGCAAC AAAG-3′, 427 bp; oligonucleotides for
hexA: forward, 5′-CATATGTAAA TGCAAATCGT CCGAT
AATG-3′; reverse, 5′-CTCGAGTGCC ATAATACCGG TGTTG-
3′, 519 bp) and X. nematophila HGB081 (oligonucleotides for
leuO: forward, 5′-CATATGACTG GATACAACTC GGTAACC-
3′; reverse, 5′-CTCGAGGGTT ATAACTGATG ACAAACTCTA
TTTCC-3′, 517 bp; oligonucleotides for lrp: forward, 5′-
CATATGATTG ATAATAAGAA GCGTCCAGGA AAAG-3′;
reverse, 5′-CTCGAGCTCT GTTTTACTTC TTCCATAACA
ACATAAGTGC-3′, 476 bp) were amplified from genomic
DNA with overhangs for NdeI and XhoI (bold) and subcloned
into pJET1.2 (Life Technologies). After digestion with the
corresponding enzymes and clean up (gel electrophoresis and
extraction), the fragments were cloned into the corresponding
sites of the previously described pCEP vector (Bode et al., 2015).
Electrocompetent S17-1 λpir cells were transformed with these
plasmids. Positive clones (selected on chloramphenicol plates)
were then used for conjugation, so that the plasmid could
be integrated into P. luminescens TTO1 and X. nematophila
HGB081 by homologous recombination. Selective media
containing rifampicin and chloramphenicol were used for
identification of positive clones. The resulting four mutant
strains, P. luminescens PBAD-leuO or PBAD-lrp and X. nematophila
PBAD-leuO or PBAD-lrp were verified by PCR and sequencing.
To create promoter activity reporters for the gene clusters
encoding xenematide (xene) or xenortide (xenor) biosynthesis
enzymes, vector pYEYP2.2 (details and DNA sequence are
depicted in the Supplementary Table S2) was constructed by
exchanging the reporter gene gfpmut3.1 on pFU69 (Uliczka
et al., 2011) with the reporter gene ypet, encoding an optimized
yellow fluorescent protein (Nguyen and Daugherty, 2005) (Life
Technologies). ypet as well as the kanR resistance cassette
were cloned into low copy vector pFU99 (Uliczka et al., 2011),
thereby replacing the lacZ and cmR genes and generating
pYEYP2.2 (pSC101∗, kanR, ypet). Promoter regions PXene
(oligonucleotides: forward, 5′-ATATCTCGAG CGCCTTACAT
CTACAAGCCA-3′ and reverse, 5′-ATATGCTAGC AATAA
ATTATACGAA TGTATTCCGT TTACAAG-3′, 446 bp)
and PXenor (oligonucleotides: forward, 5′-ATATCTCGAG
GCTAACAATA GTATGTTAGC ATGGC-3′ and reverse,
5′-ATATGCTAGC ATGGTACTTT TTACCTTTCT GTG-3′,
392 bp) were amplified with overhangs for XhoI and NheI
(bold). The corresponding restriction enzyme sites were
then used for insertion of the promoter regions into the
pYEYP2.2 vector. E. coli DH10B was used for these cloning
procedures.
Transformation of Xenorhabdus Strains
Promoter reporter and overexpression plasmids were
transformed into X. nematophila and X. szentirmaii via
heat shock transformation as described previously (Xu et al.,
1989). For this purpose, cultures were grown to OD600 ∼0.6 and
1 mL culture was harvested for each individual transformation.
Positive clones were isolated on selective media according to
antibiotic resistance encoded on the vector.
Extraction of Natural Products from
Bacterial Cultures
For direct extraction of cultures, cells were inoculated with OD600
0.1 in SF-900 broth (GibcoTM) (or sorted and inoculated in
LB for the FACS analysis) and incubated for 3 days at 30◦C,
200 rpm. Subsequently, equal amounts of culture and methanol
were mixed. After centrifugation the supernatant was directly
analyzed via high performance liquid chromatography coupled
with mass spectrometry (HPLC-MS).
Cultures for the heterologous leuO overexpression in
X. szentirmaii were inoculated with OD600 0.1 in LB,
supplemented with 2% (v/v) Amberlite XAD-16 and harvested
after 3 days of cultivation by decanting cells and supernatant.
The XAD-16 beads were extracted with methanol with one
culture volume for 1 h while stirring. After filtration the extract
was evaporated to dryness. For HPLC-MS analysis the extract
was redissolved in MeOH in the original culture volume.
HPLC-MS Analysis
Extracts were analyzed using the UltiMate 3000 LC System
(Dionex) coupled to an amaZon X ion trap with electrospray
ionization (Bruker Daltonics). A water/acetonitrile gradient
with 0.1% formic acid as mobile phase with 0.4 mL/min
flow separated the compounds on a C18 column (ACQUITY
UPLC BEH, 1.7 mm, Waters). Relative amounts were quantified
either directly by integration of the area peak in DataAnalysis
4.2 Software (Bruker Daltonics) or by using Target Analysis
(Bruker Daltonics) with the recently described setup (Ahrendt
et al., 2015). The m/z ratios that were used for this procedure
are as follows: m/z 215.2 [M+H]+ (desmethylphurealipid A),
m/z 586.4 [M+H]+ (GameXPeptide A), m/z 552.4 [M+H]+
(GameXPeptide C) [M+H]+, m/z 255.1 [M+H]+ (IPS), m/z
334.7 [M+2H]2+ (mevalagmapeptide), m/z 273.2 [M+H]+
(nematophin), m/z 229.2 [M+H]+ (phurealipid A), m/z 295.2
[M+H]+ (photopyrone D), m/z 574.4 [M+H]+ (rhabdopeptide
1), m/z 838.4 [M+H]+ (szentiamide), m/z 663.3 [M+H]+
(xenematide A), m/z 466.3 [M+H]+ (xenocoumacin 1), m/z
281.1 [M+H]+ (xenofuranone A), and m/z 410.3 [M+H]+
(xenortide A). All analyses were performed in triplicate. Base
peak chromatograms and extracted ion chromatograms (EICs)
displayed in some figures were also created with DataAnalysis 4.2
(Bruker Daltonics).
FACS Analysis
Fluorescence activated cell sorting (FACS) analysis and cell
sorting were performed on a FACS AriaIII cell sorter (BD
Biosciences). YPet was excited with a 488 nm Laser. The filter
set up for the YPet channel is 530/30 nm with a 502 LP mirror.
At 24 h post-inoculation, 10 µL of culture were diluted with
5 mL phosphate buffered saline (PBS) and one million cells were
sorted into 2× LB for each condition to remove dead or inactive
cells. These sorted cells were then inoculated into fresh LB with
and without arabinose supplementation. Fluorescence analysis
was carried out 2 days after this inoculation. For each analysis
the culture was diluted 100× with PBS and 50,000 events were
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recorded with the same instrumental adjustments. At the same
time samples for direct HPLC-MS analysis were collected.
Microarray Analysis
Tiled microarrays were used to measure transcript levels
in X. nematophila wild type (HGB800) and lrp-2::Km early
stationary phase cells as previously reported (Hussa et al., 2015)
to compare the expression levels of biosynthesis genes. Briefly,
the average signal strength of all probes was used as the baseline
signal strength level and genes with average signal strength
(across probes within that gene) of at least five times this
amount were considered expressed. For these genes, the baseline
signal strength value was subtracted from the average signal
strength for the gene, and all genes were normalized across
strains using the values for the recA gene. Differences between
strains in normalized values of at least twofold were considered
differentially expressed. Data shown in Table 1 represent a subset
of genes from this analysis.
RESULTS
Effects of Lrp, LeuO, and HexA on
Selected Natural Products in
Photorhabdus and Xenorhabdus
To investigate the effects of the global regulators Lrp, LeuO, and
HexA on secondary metabolism we created mutants in which
the natural promoter of each of these global regulators was
exchanged with the inducible PBAD promoter via homologous
recombination using the recently described, integrative pCEP
vector (Bode et al., 2015). The PBAD promoter is tightly regulated
in Xenorhabdus and Photorhabdus (Bode et al., 2015), allowing
us to control the levels of LeuO or Lrp expressed (either
TABLE 1 | Summary of regulatory effects of Lrp and LeuO on secondary
metabolite production in P. luminescens and X. nematophila.
Compound Lrp LeuO HexA
Photorhabdus luminescens
Mevalagmapeptide ↓ − ↓
Photopyrone D ↑ − ↓
GameXPeptide A ↑ ↑ ↓
Isopropylstilbene − ↑ ↓
Phurealipid A ↑ ↓ ↓
Desmethylphurealipid A ↑ ↓ ↓
Xenorhabdus nematophila
Nematophin ↓ ↓
Xenematide A ↑ ↑
Xenocoumacin 1 ↑ ↓
Xenortide A ↑ ↓ −
Rhabdopeptide 1 ↑ ↓
Xenotetrapeptide ↓ ↑
Downward and upward arrows indicate negative and positive regulation by the
regulator, respectively, while hyphen marks no significant change. Arrow and
hyphen together show a trend, meaning that a clear difference was observable
between wild type and non-induced culture but not between induced and non-
induced mutant.
no expression or induced expression) and study downstream
regulatory effects. The resulting mutants were grown for 3 days
in SF-900 broth, which is a medium for cultivation of insect cell
lines and should therefore provide growth conditions that are
closer to natural hosts than LB. Extracts were obtained using
methanol directly from the cultures and analyzed by HPLC-MS
as described in Section “Materials and Methods.” The resulting
production was divided by the OD600 of the cultures as we
observed that some induced and non-induced cultures showed
slight differences in their OD600 relative to the non-modified
wild type cultures (induced: P. luminescens PBAD-lrp: 0.8×, PBAD-
leuO: 1.1×, PBAD-hexA: 0.7×, X. nematophila PBAD-lrp: 1×,
PBAD-leuO: 0.7×; non-induced: P. luminescens PBAD-lrp: 1.2×,
PBAD-leuO: 0.8×, PBAD-hexA: 0.6×, X. nematophila PBAD-lrp:
0.8×, PBAD-leuO: 1.1×). We found that P. luminescens Lrp and
LeuO both had either positive or a negative effects on metabolite
production, depending on the natural product class while HexA
decreased production for all of these compounds (Figure 2A).
In the non-induced P. luminescens PBAD-lrp and PBAD-hexA
strains, we detected four and five times more mevalagmapeptide
(Bode et al., 2015) compared to either the wild type or the
induced PBAD-lrp and PBAD-hexA strains, respectively. Thus,
Lrp and HexA act as negative regulators of mevalagmapeptide
biosynthesis. In contrast, leuO induction had no influence on
mevalagmapeptide production. Wild type cultures had higher
levels of several compounds including photopyrone D (Nollmann
et al., 2015b) and GameXPeptide A (Bode et al., 2012) compared
to the non-induced PBAD-lrp culture, suggesting a role as an
activator. However, the induced cultures failed to reach wild
type levels (GameXPeptide). The amount of phurealipid A in
the induced PBAD-lrp strain is also lower than in the wild type,
however, its precursor desmethylphurealipid A (Nollmann et al.,
2015b) is produced by the PBAD-lrp mutant in higher amounts
relative to wild type if lrp expression is induced. In summary,
the data shows that in P. luminescens, Lrp positively regulates
production of GameXPeptide A and desmethylphurealipid A,
activate photopyrone D and phurealipid A production to a lesser
extent, and negatively regulates mevalagmapeptide, but does not
significantly affect IPS production.
Based on metabolites produced in the induced versus non-
induced cultures of the P. luminescens PBAD-leuO mutant, LeuO
positively influences GameXPeptide A, and IPS production,
while it negatively impacts phurealipid A biosynthesis.
Desmethylphurealipid A production is hardly influenced by
LeuO and the regulation on photopyrone D is not clearly
distinguishable. Therefore, P. luminescens LeuO acts as both an
activator and repressor.
The induced PBAD-hexA strain shows strongly decreased
production of all compounds that were analyzed while the non-
induced strain produces higher amounts of mevalagmapeptide
(∼5.6×), IPS (∼5.7×), and desmethylphurealipid A (∼4.7×)
compared to the wild type while the amounts of photopyrone D
and phurealipid A are lower.
In contrast to P. luminescens the effects of lrp on secondary
metabolites in X. nematophila are more dramatic: compared
to wild type X. nematophila, the non-induced PBAD-lrp
mutant strain produces significantly lower levels (∼0.01× to
∼0.28×) of the examined secondary metabolites except for
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FIGURE 2 | Continued
FIGURE 2 | Relative production of selected natural products in
P. luminescens PBAD-lrp (lrp), PBAD-leuO (leuO), and PBAD-hexA (hexA)
(A), and X. nematophila HGB081 PBAD-lrp (lrp) and PBAD-leuO (leuO) (B)
compared to the respective wild type strains. For induction of PBAD, cultures
were supplemented with 0.2% arabinose (+). Average production of the
triplicates (three individual cultures inoculated from the same preculture) was
divided by average OD600 values and normalized to the appropriate wild type
strains without addition of arabinose (−). Error bars indicate the standard
deviation. Values for compounds produced in very low amounts are presented
above the corresponding bars.
nematophin (Li et al., 1997) and xenotetrapeptide (Kegler et al.,
2014). Induced expression of lrp restores the production to
approximately wild type levels for xenematide A (Lang et al.,
2008), xenocoumacin 1 (McInerney et al., 1991), xenortide A
(Lang et al., 2008), and rhabdopeptide 1 (Reimer et al., 2013)
(Figure 2B), indicating that Lrp is predominantly a positive
regulator of secondary metabolite production. In contrast, LeuO
positively regulates the production of xenotetrapeptide (Kegler
et al., 2014) and xenematide A. Compared to non-inducing
conditions, the PBAD−leuO mutant produced less nematophin
(∼0.6×), xenocoumacin 1 (∼0.4×) (McInerney et al., 1991),
rhabdopeptide 1 (∼0.5×), and xenortide A (Lang et al., 2008).
These data indicate that LeuO can act directly or indirectly as a
repressor or activator of X. nematophila secondary metabolism.
The analyses described above provided an opportunity to
search for previously not described natural products that might
be produced by the various strains we tested. Toward this end
we compared the base peak chromatograms of the wild type and
the induced and non-induced PBAD-lrp mutants (Figure 3A). In
several cases, clear differences in peak intensities were observed
among strains. We examined the mass spectra at the same
retention times to find the m/z ratios of the compounds that
are responsible for the observed differences. Corresponding
EICs for those m/z values that do not belong to the already
mentioned compounds or their derivatives were generated to
display these findings (Figures 3B–J). We identified eight new
compounds produced by P. luminescens (Figures 3B–I; m/z
312.1 [M+H]+, m/z 326.0 [M+H]+, m/z 420.1 [M+H]+, m/z
317.0 [M+H]+, m/z 321.1 [M+H]+, m/z 379.2 [M+2H]2+, m/z
315.1 [M+H]+, m/z 452.1 [M+H]+). With one exception, each
of these individual compounds is present at similar levels in
both the wild type and the induced PBAD-lrp mutant. Only m/z
321.1 [M+H]+ had a significantly higher production level in the
induced PBAD-lrp mutant than in the wild type. Surprisingly,
we also found two compounds that are mainly produced in
the non-induced PBAD-lrp mutant (m/z 315.1 [M+H]+, m/z
317.0 [M+H]+). For X. nematophila we observed one additional
compound (Figure 3J; m/z 428.2 [M+H]+) that is produced in
higher amounts in the induced PBAD-lrp mutant culture than in
the non-induced culture. All regulatory effects are summarized in
Table 1.
Microarray Analysis
A previously reported microarray analysis (Hussa et al., 2015)
was mined to examine the influence of Lrp on expression
levels of genes encoding (or predicted to encode) secondary
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FIGURE 3 | HPLC-MS analysis of natural product production of
P. luminescens TTO1 and X. nematophila HGB081 (A, Base peak
chromatogram). Wild type (P. luminescens: red dashed, X. nematophila: blue
dashed), wild type + 0.2% arabinose (gray dashed), PBAD-lrp (black), PBAD-lrp
+ ara (P. luminescens: green, X. nematophila: orange). (1) m/z 379.2
[M+2H]2+, (2) m/z 312.1 [M+H]+, (3) m/z 321.1 [M+H]+, (4) m/z 420.1
[M+H]+, (5) m/z 326.0 [M+H]+, (6) m/z 317.0 [M+H]+, (7) m/z 315.1
[M+H]+, (8) anthraquinone, (9) m/z 452.1 [M+H]+, (10,11) xenocoumacins,
(12,14) xenortides, (13) m/z 428.2 [M+H]+, (15,16) rhabdopeptides, (17)
rhabdopeptide and nematophin (B–J). Extracted ion chromatograms (EIC) of
unidentified regulated compounds in PBAD-lrp (black), PBAD-lrp + ara
[P. luminescens (B–I): green, X. nematophila (J): orange]. (K) Comparison of
base peak chromatograms of P. luminescens (blue) and X. nematophila (red)
wild type cultures grown on LB (continuous line) or SF900 medium (dashed
line) and corresponding media controls (black).
metabolite biosynthetic activities. Expression levels of genes
within 12 different gene clusters were compared between
a X. nematophila lrp-2::kan mutant (Cowles et al., 2007)
and its wild type parent (Table 2). Consistent with our
metabolite analyses described above, these data indicate that
Lrp positively influences the expression of genes involved in
xenocoumacin, xenotetrapeptide, rhabdopeptides, xenortides,
and xenematides. The genes that encode for PAX-peptide
biosynthesis, a compound class that could not be quantified
with our HPLC-MS system, were also positively regulated by
Lrp. Six additional putative biosynthesis genes or gene clusters
of which the biosynthesis product is unknown, also displayed
higher levels of expression in wild type relative to the lrp
mutant. Only one putative biosynthesis gene (XNC1_2799)
displayed negative regulation by Lrp. Overall, the microarray
results provide evidence that Lrp influences secondary metabolite
production at the level of gene expression (transcription or RNA
stability).
Lrp Influences Promoter Activity
To further explore the influence of Lrp on transcription
of secondary metabolite gene clusters, we created reporter
constructs that placed the yellow-fluorescent-protein YPet under
control of the promoters driving expression of Lrp-dependent
xenematide A (xene) and xenortide A (xenor) biosynthesis
genes: PXene-ypet and PXenor-ypet reporters, respectively. These
reporters and a negative control (nc, promoterless reporter
plasmid) were expressed in X. nematophila PBAD-lrp from
low-copy plasmids (pYEYP2.2) and analyzed by FACS-analysis
under non-inducing and inducing growth conditions. Increased
promoter activity, based on YPet fluorescence, was observed on
single cell level when lrp was induced with arabinose for PXene
and PXenor, suggesting an effect on transcriptional regulation
of the corresponding biosynthesis genes by Lrp (Figure 4A).
Extracts of the same cultures supports these findings as the
induced cultures contain a higher level of the corresponding
compounds (Figure 4B).
Effects of Heterologous Expression of
leuO on Metabolite Production
Based on our finding that induced expression of lrp and
leuO could reveal previously unidentified compounds, we
considered the possibility that their ectopic expression in
a heterologous host might allow expanded natural product
discovery. To test if LeuO could function to control secondary
metabolite production in a heterologous host, we generated
pBAD30_kanR-based arabinose-inducible overexpression
plasmids pBAD30_kanR_leuO_P encoding LeuO from
P. luminescens and pBAD30_kanR_leuO_X encoding LeuO from
X. nematophila. When these were expressed in X. szentirmaii we
found that induced expression of X. nematophila leuO had major
effects on secondary metabolite production while P. luminescens
leuO induction did not visibly alter production of tested
compounds (Figure 5). As in the endogenous X. nematophila
strain, it had both positive and negative consequences on
compound production in X. szentirmaii. Production of
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GameXPeptide C, the main GameXPeptide derivative in
X. szentirmaii, is increased sixfold while xenofuranone
(Brachmann et al., 2006) and szentiamide (Ohlendorf et al.,
2011) production were reduced to ∼0.1× and ∼0.2× compared
to the wild type, respectively (Figure 5). By comparison of
the induced and non-induced base peak chromatograms new
TABLE 2 | Fold differences in gene expression levels of X. nematophila HGB800 wild type (wt) versus lrp-2::kan (HGB1059).
Natural product ID Annotation wt/lrp
Unknown XNC1_0646 Non-ribosomal peptide synthetase (NRPS, fragment) 13.75
Unknown XNC1_1561 NRPS 14.98
Xenocoumacins XNC1_1698 Desaturase XcnN 3.43
XNC1_1699 Dehydrogenase XcnM 8.00
XNC1_1700 Polyketide synthase (PKS) XcnL 11.15
XNC1_1701 Non-ribosomal peptide synthase XcnK 12.11
XNC1_1702 Conserved hypothetical protein XcnJ 9.62
XNC1_1703 Thioesterase XcnI 11.81
XNC1_1704 PKS XcnH 13.41
XNC1_1705 Peptidase XcnG 11.04
XNC1_1706 PKS XcnF 12.05
XNC1_1707 Acyl-CoA dehydrogenase XcnE 15.66
XNC1_1708 Putative acyl carrier protein XcnD 14.14
XNC1_1709 Methoxymalonate biosynthesis protein XcnC 18.31
XNC1_1710 3-hydroxyacyl-CoA dehydrogenase XcnB 17.77
XNC1_1711 NRPS XcnA 12.43
Xenotetrapeptide XNC1_2022 NRPS XtpS 2.14
Unknown XNC1_2038 NRPS 2.15
XNC1_2039 NRPS 2.68
XNC1_2040 NRPS 2.11
Unknown XNC1_2152 Hypothetical protein 3.67
XNC1_2153 Arginine aminomutase 29.52
XNC1_2154 Aminotransferase 16.99
XNC1_2155 Putative clavaminate synthase 11.40
XNC1_2156 PKS 9.17
XNC1_2157 PKS/NRPS hybrid 5.75
XNC1_2158 Putative membrane protein 5.41
XNC1_2159 Putative 2-dehydropantoate 2-reductase 4.05
XNC1_2160 Putative dioxygenase 2.88
XNC1_2161 NRPS 3.04
XNC1_2162 Thioesterase (fragment) 2.47
Rhabdopeptides XNC1_2228 NRPS RdpA 6.37
XNC1_2229 NRPS RdpB 8.50
XNC1_2230 NRPS RdpC 7.46
Unknown XNC1_2233 NRPS 2.03
Xenortides XNC1_2299 NRPS XndA 3.57
XNC1_2300 NRPS XndB 4.50




XNC1_2468 Putative N-acetyltransferase 3.99
XNC1_2469 Putative hydroxylase 5.06
XNC1_2470 Putative aminotransferase 5.67
Xenematides XNC1_2713 NRPS 5.33
PAX-Peptides XNC1_2781 NRPS XpsB 8.91
XNC1_2782 NRPS XpsB 9.93
XNC1_2783 NRPS XpsA 10.14
XNC1_2784 Putative ABC transporter 10.10
Unknown XNC1_2799 NRPS (fragment) 0.36
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FIGURE 4 | FACS analysis detecting YPet (yellow fluorescent protein)
fluorescence intensity (per individual cell) of 50,000 events for each
condition (A) and HPLC-MS analysis (B) detecting xenematide A (1–4) or
xenortide A (5–8). Analyses were performed on X. nematophila HGB081
PBAD-lrp carrying ypet promoter-reporter plasmids for PXene (1, 2) or PXenor (5,
6) or an empty vector negative control (nc; 3, 4, 7, 8). Strains were either
induced (+ara) or not induced by addition of 0.2% arabinose to growth
cultures. (1–4) EIC m/z 466.3 [M+H]+ for xenematide A. (5–8) EIC m/z 410.3
[M+H]+ for xenortide A. Figure 4A was created with FCS Express 5.
compounds with m/z 659.3 and 772.3 [M+H]+ were identified
(Figure 5) that might belong to the family of rhabdopeptides
due to their characteristic fragmentation pattern [Reimer et al.,
2013; see Supporting Information (Supplementary Figure S1)]
as well as m/z 531.3 [M+2H]2+ and m/z 630.3 [M+2H]2+
FIGURE 5 | Production of selected natural products after heterologous
expression of leuO from P. luminescens TTO1 (P) and X. nematophila
HGB081 (X) in X. szentirmaii compared to wild type and vector control
(vc) as analyzed by HPLC-MS. Cultures supplemented with 0.2%
arabinose for PBAD induction are striped and marked with (+) otherwise with
(−). (A) Average production of the triplicates (three individual cultures
inoculated from the same preculture) was normalized to the appropriate wild
type strains without addition of arabinose (−), error bars mark the standard
deviation. Values for compounds produced in very low amounts are presented
above the corresponding bars. (B) EICs of regulated but structurally unknown
compounds.
which are structurally still unknown. High resolution high
performance liquid chromatography coupled with mass
spectrometry (HR-HPLC-MS) suggests a sum formula of
C52H92N11O12 for m/z 531.3 [M+2H]2+ indicating a peptide
structure.
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DISCUSSION
The Role of Lrp, LeuO, and HexA on
Natural Product Biosynthesis in
Entomopathogenic Bacteria
Understanding the regulation of natural product biosynthesis
is an important step toward predicting the function of
natural products if it is known under which conditions the
regulators are active. The regulatory cascades controlling natural
product biosynthesis have not been investigated in detail in
entomopathogenic bacteria. The global regulator HexA has
already been the focus of several studies on Photorhabdus
and was found to play an important role as a repressor
in the nematode host. It has been reported that it has an
impact on IPS and anthraquinone biosynthesis (Kontnik et al.,
2010) and that HexA itself is regulated by another global
regulator. A1hfq mutant hardly produces secondary metabolites
while an additional deletion of hexA restores the production
(Tobias et al., 2016). We wanted to enhance these studies with
the focus on additional compounds directly comparing hexA
inducing and non-inducing conditions. Indeed we observed
that HexA generally acts as a repressor for all compounds
that have been analyzed in P. luminescens. Lrp as a global
transcriptional regulator has been reported in both Photorhabdus
and Xenorhabdus, but not directly upon natural product BGC
(Cowles et al., 2007; Kontnik et al., 2010; Lango-Scholey
et al., 2013; Hussa et al., 2015). The greatest influence of
P. luminescens TTO1 Lrp on a known compound is the
overproduction of desmethylphurealipid A (∼4×) while LeuO
has very little effect (Figure 2). Overproduction (5×) for
this compound was also observed in the non-induced PBAD-
hexA strain. In vivo experiments in which this compound
and other phurealipids were injected into Galleria mellonella
and Manduca sexta larvae showed reduced levels of mRNA
for insect antimicrobial-peptide-encoding genes suggesting a
role for these molecules in insect pathogenicity (Nollmann
et al., 2015b). In contrast, the non-induced Lrp and HexA
mutant both produce significantly more mevalagmapeptide than
the wild type (∼4× and ∼5×, respectively) or the induced
mutant. The role of mevalagmapeptides for the producing
organism has yet to be established. Lrp has previously been
reported to have either no significant (Kontnik et al., 2010),
as well as activating effects (Lango-Scholey et al., 2013), on
IPS biosynthesis. Lango-Scholey et al. (2013) suggested that
this discrepancy might be due to small differences in the
corresponding lab strains. In our study, we found little influence
of Lrp on stilbene production. However, we saw activation by
LeuO on its biosynthesis, while HexA represses it. If hexA
is not induced, IPS levels are ∼6× above wild type level,
which supports previous studies (Kontnik et al., 2010). We
suggest that other factors such as nutrients might play an
additional role for Lrp in regulating IPS biosynthesis, as we
also observed an increase in IPS production for the induced
strain when LB was used for cultivation instead of SF-900 broth
(data not shown). For the decreased IPS production in the
absence of Lrp observed by Lango-Scholey et al. (2013), the
limiting factor appeared to be the branched-chain α-ketoacid
dehydrogenase encoded in the bkdABC operon that is part of
the IPS biosynthesis pathway (Joyce et al., 2008) and is also
responsible for the production of branched chain fatty acids
(BCFAs) in P. luminescens (Lango-Scholey et al., 2013). BCFAs
are also part of the photopyrone and phurealipid biosynthesis
and their production is also negatively affected by the absence of
Lrp. The photopyrones are signal molecules inducing production
of the Photorhabdus clumping factor (pcf ) through a recently
described cell–cell communication system (Brachmann et al.,
2013). Heterologous expression of the pcf operon in E. coli
greatly enhanced the toxicity toward insect larvae, demonstrating
the contribution of photopyrones toward the virulence of
P. luminescens.
Except for nematophin and xenotetrapeptide, Lrp strongly
activates secondary metabolite production in X. nematophila,
while LeuO attenuates the production of most examined
natural products, including nematophin. Nematophin possesses
antifungal and antibacterial activities (Li et al., 1997) that might
be restricted to Staphylococcus strains (Kennedy et al., 2000)
although Lang et al. (2008) could neither reproduce these effects,
nor could they determine an activity against other bacterial
species. Xenocoumacins, xenematides, and xenortides display
antimicrobial activity against a broad spectrum of bacteria
(Lang et al., 2008) and are thought to eliminate microbial
competitors to defend the nutrients within the insect cadaver.
Xenematides have insecticidal activity, rhabdopeptides are active
against insect hemocytes (Lang et al., 2008; Reimer et al.,
2013), and xenortides are cytotoxic against mammalian L6
cells (Reimer et al., 2014). The regulation of these compounds
by Lrp is in agreement with the previously reported finding
that this regulator is needed for virulence (Cowles et al.,
2007). Additionally, we show that Lrp affects promoter activity
for PXene and PXenor (Figure 4A). Consistent with these
data, microarray analysis revealed Lrp-dependent regulation of
the known biosynthesis genes and clusters for xenematides,
xenortides, rhabdopeptides, xenocoumacins, and PAX-peptides,
as well as six other biosynthetic genes of which the exact
function is as yet unknown. Each of these clusters was identified
through RNAseq analysis as being positively regulated by the
global regulator FliZ in the F1 strain of X. nematophila (Jubelin
et al., 2013). Since Lrp also positively regulates fliZ the likely
regulatory hierarchy is one in which Lrp positively regulates
FliZ, which in turn activates expression of biosynthetic clusters
(Hussa et al., 2015). However, members of the Lrp regulon
that are either directly or indirectly regulated by Lrp remain to
be distinguished. The microarray analysis also shows a slightly
higher gene expression for the xenotetrapeptide biosynthesis
gene although the relative quantification of this compound
revealed a slight downregulation by Lrp. This discrepancy may be
explained by differences in growth conditions (LB versus SF-900)
or strain identities (ATCC19061 versus AN6/1). One biosynthetic
gene, XNC1_2799 is apparently negatively regulated by Lrp.
LeuO in X. nematophila acts as a repressor for all examined
secondary metabolites except xenotetrapeptide and xenematide
A, analogous to its role in V. cholerae, V. parahaemolyticus,
and S. enterica in which this regulator attenuates virulence
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(Whitaker et al., 2012; Bina et al., 2013; Espinosa and Casadesús,
2014). This is in contrast to P. luminescens TTO1 where
LeuO acts as an activator as well as a repressor of secondary
metabolism.
As we found that the non-induced PBAD-lrp mutants produced
a significantly lower amount of several compounds but the
induced expression of Lrp did not fully restore the production,
it is likely that the induced constitutive expression does not reach
the natural Lrp levels.
Heterologous Expression of leuO
Reveals Control on Secondary
Metabolism in X. szentirmaii
Surprisingly, we found that expression of X. nematophila leuO
in X. szentirmaii has a major influence on secondary metabolite
expression while P. luminescence leuO has no effects (Figure 5).
The X. nematophila and X. szentirmaii LeuO sequences are more
similar to each other (90% based on blastx analysis) than either
is to P. luminescens LeuO (71 and 71%, respectively) indicating
that the P. luminescens regulator may not be functional in
Xenorhabdus strains. The impact of LeuO on the synthesis of
two natural products is particularly notable when comparing
these three organisms. In P. luminescens and X. szentirmaii
GameXPeptides are positively regulated by leuO expression.
Similarly, rhabdopeptide biosynthesis in X. nematophila and
X. szentirmaii is attenuated by LeuO. The finding that the global
regulator LeuO controls the production of the same compound
classes indicates that, to some extent, it plays a similar role in
the different entomopathogenic Photorhabdus and Xenorhabdus
species.
Global Regulators as Tools for the
Discovery of New Secondary Metabolites
and Increased Production of Useful
Molecules
The development of new drugs, especially new antibiotics,
is an important research area as resistances against common
antibiotics are increasing dramatically (WHO, 24 July 2015).1
The entomopathogenic Photorhabdus and Xenorhabdus spp. are
a rich source of compounds with antimicrobial bioactivity, but
isolation for structural characterization and bioactivity assays is
often problematic as the amounts are often low. One method
for improving biosynthesis is the exchange of the promoter
in front of the biosynthesis gene (Bode et al., 2015) or
heterologous expression (Schimming et al., 2014). Unfortunately,
these approaches require knowledge about the biosynthetic
pathways and the genes necessary for their expression. In the
case of heterologous expression another issue is that some
biosynthetic precursors might be missing in the heterologous
host organism (Nollmann et al., 2015a). One approach that avoids
these issues is to elicit overproduction of the molecule(s) in the
original producers without knowledge of the relevant biological
pathways. Based on the work presented here, the global regulators
Lrp and LeuO could be exploited for this approach. For example,
1www.who.int/mediacentre/factsheets/fs194/en/
overproduction could be achieved by expression of regulators
under control of a strong constitutive promoter, or the use of
a replicative overexpression plasmid. The potential success of
this strategy is supported by our finding that ectopic expression
of the X. nematophila LeuO regulator in X. szentirmaii led to
overproduction of the GameXPeptide (Figure 5). Further, this
approach can also reveal previously unrecognized compounds,
such as the two compounds with m/z 531.3 [M+2H]2+ and
m/z 630.3 [M+2H]2+ expressed by X. szentirmaii carrying
the X. nematophila LeuO. The heterologous overexpression
of activators like LeuO or Lrp from diverse Photorhabdus
and Xenorhabdus strains offers the possibility to increase the
production of specific compounds in strains that have not been
sequenced yet.
Although requiring a priori knowledge of genome sequence,
the inducible production of Lrp in endogenous hosts also has the
power to reveal novel compounds. For instance, by comparing
base peak chromatograms and the corresponding mass spectra,
we identified nine new compounds produced by P. luminescens
and X. nematophila. This discovery might mainly be due to the
use of SF-900 broth, a medium that is used for culturing insect
cell lines instead of the normally used LB, as most compounds
were also present in the wild type and the production levels
between wild type and the induced mutant were similar for the
individual compounds. Three of these natural products were
produced in significantly higher amounts in the induced (m/z
321.1 [M+H]+) or non-induced (m/z 315.0 [M+H]+, m/z 317.0
[M+H]+) P. luminescens PBAD-lrp mutant than in the wild type,
suggesting the capacity of this approach to expand the discernible
array of secondary metabolites. For comparison of production in
SF900 and LB, the base peak chromatograms of P. luminescens
and X. nematophila extracts are displayed in Figure 3K. It is
visible that components of LB disturb the chromatogram between
retention time (RT) 5–7 min while it is easier to observe new
compounds in the cleaner background of SF900 medium.
CONCLUSION
We have established that the global regulators Lrp, HexA, and
LeuO are involved in the regulation of secondary metabolism
in X. nematophila and P. luminescens, with different effects
(activating, repressing, or both) depending on the organism
and the individual natural products. A potential for increasing
secondary metabolites in heterologous hosts has been shown
for X. nematophila LeuO in X. szentirmaii. The heterologous
expression of lrp and leuO in other organisms remains to
be studied but promises to reveal previously unrecognized
metabolites.
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